Published in Int J Sports Med on November 28, 2006
Exercise induced adipokine changes and the metabolic syndrome. J Diabetes Res (2014) 1.12
Relationships between plasma adiponectin and body fat distribution, insulin sensitivity, and plasma lipoproteins in Alaskan Yup'ik Eskimos: the Center for Alaska Native Health Research study. Metabolism (2009) 0.94
Adiponectin: an adipokine with protective features against metabolic syndrome. Iran J Basic Med Sci (2015) 0.87
Unique profile of chicken adiponectin, a predominantly heavy molecular weight multimer, and relationship to visceral adiposity. Endocrinology (2009) 0.84
Enhanced insulin sensitivity after acute exercise is not associated with changes in high-molecular weight adiponectin concentration in plasma. Eur J Endocrinol (2009) 0.76
The Effects of Aerobic Exercise on Plasma Adiponectin Level and Adiponectin-related Protein Expression in Myocardial Tissue of ApoE(-/-) Mice. J Sports Sci Med (2015) 0.75
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15
Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (1994) 8.85
Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab (1998) 3.78
Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem (1985) 3.76
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
Metaphyseal chondrodysplasia, Schmid type. Clinical and radiographic delineation with a review of the literature. Pediatr Radiol (1988) 2.06
Errors of morphogenesis: concepts and terms. Recommendations of an international working group. J Pediatr (1982) 2.04
Progressive pseudorheumatoid arthritis of childhood (PPAC). A hereditary disorder simulating rheumatoid arthritis. Eur J Pediatr (1983) 1.98
Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut (2007) 1.85
Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. J Clin Endocrinol Metab (1992) 1.82
A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)--Potsdam Study cohort. Diabetologia (2005) 1.79
Malformations in newborn: results based on 30,940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990-1998). Arch Gynecol Obstet (2002) 1.79
Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia (2006) 1.78
Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy. J Clin Endocrinol Metab (2011) 1.75
Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes (2001) 1.70
Spondyloepiphyseal dysplasia. Birth Defects Orig Artic Ser (1974) 1.60
Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature (1997) 1.60
Insulin allergy: clinical manifestations and management strategies. Allergy (2008) 1.56
Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells. Diabetologia (2009) 1.55
Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS. Infect Immun (1990) 1.54
Crystal structure of human frataxin. J Biol Chem (2000) 1.54
The comparison of venous plasma glucose and whole blood capillary glucose in diagnoses of Type 2 diabetes: a population-based screening study. Diabet Med (2005) 1.53
Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem. Front Immunol (2012) 1.50
"New" dwarfing syndromes. Birth Defects Orig Artic Ser (1977) 1.49
Short rib-polydactyly (SRP) syndromes, types Majewski and Saldino-Noonan. Z Kinderheilkd (1974) 1.48
Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr (2000) 1.48
Duplicate publication and related problems. Pediatrics (1990) 1.46
Further delineation of the 3-M syndrome with review of the literature. Am J Med Genet (1987) 1.43
Osteogenesis imperfecta: a clinical study of the first ten years of life. Calcif Tissue Int (1992) 1.43
Mental retardation syndrome with renal concentration deficiency and intracerebral calcification. Eur J Pediatr (1990) 1.40
[Lipomucopolysaccharidosis, A new storage disease]. Z Kinderheilkd (1968) 1.38
Hypochondroplasia: clinical and radiological aspects in 39 cases. Radiology (1979) 1.34
Kniest and Stickler dysplasia phenotypes caused by collagen type II gene (COL2A1) defect. Nat Genet (1993) 1.31
Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metab (2009) 1.30
Recessively inherited multiple epiphyseal dysplasia with normal stature, club foot, and double layered patella caused by a DTDST mutation. J Med Genet (1999) 1.29
Mucopolysaccharidosis. VII. Beta-glucuronidase deficiency. Humangenetik (1974) 1.26
A new familial intrauterine growth retardation syndrome the "3-M syndrome". Eur J Pediatr (1976) 1.24
New isoniazid/ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains. Lancet (1995) 1.24
[Dysosteosclerosis--a special form of generalized osteosclerosis]. Fortschr Geb Rontgenstr Nuklearmed (1968) 1.22
Wormian bones in osteogenesis imperfecta and other disorders. Skeletal Radiol (1982) 1.21
[Metatrophic dwarfism]. Arch Kinderheilkd (1966) 1.21
[The campomelic syndrome]. Presse Med (1971) 1.21
Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS). Diabet Med (2015) 1.18
Mucolipidosis I: increased sialic acid content and deficiency of an alpha-N-acetylneuraminidase in cultured fibroblasts. Biochem Biophys Res Commun (1977) 1.18
Impairment of fat oxidation under high- vs. low-glycemic index diet occurs before the development of an obese phenotype. Am J Physiol Endocrinol Metab (2009) 1.18
Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest (2002) 1.17
Maroteaux-Lamy disease (mucopolysaccharidosis VI), subtype A: deficiency of a N-acetylgalactosamine-4-sulfatase. Biochem Biophys Res Commun (1974) 1.17
Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. Eur J Endocrinol (2004) 1.16
Chronic sputum production: correlations between clinical features and findings on high resolution computed tomographic scanning of the chest. Thorax (1996) 1.15
Impact of cereal fibre on glucose-regulating factors. Diabetologia (2005) 1.15
[Prevention, diagnosis, therapy, and follow-up of lung cancer]. Pneumologie (2010) 1.14
Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. J Clin Endocrinol Metab (2006) 1.13
The Dyggve-Melchior-Clausen syndrome. Radiology (1975) 1.13
The pallister mosaic syndrome. Birth Defects Orig Artic Ser (1977) 1.12
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists. Cell Death Differ (2013) 1.12
Biological activity of synthetic heptaacyl lipid A representing a component of Salmonella minnesota R595 lipid A. Eur J Biochem (1986) 1.12
Wolcott-Rallison syndrome: diabetes mellitus and spondyloepiphyseal dysplasia. Eur J Pediatr (1982) 1.12
The Pro115Gln polymorphism within the PPAR gamma2 gene has no epidemiological impact on morbid obesity. Exp Clin Endocrinol Diabetes (2002) 1.10
Congenital anomalies in children of epileptic mothers and fathers. Neuropediatrics (1980) 1.09
Therapeutic strategies in adrenal insufficiency. Ann Endocrinol (Paris) (2001) 1.09
Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients. Kidney Int (2007) 1.09
Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond) (2005) 1.08
The clinical spectrum of alpha-L-iduronidase deficiency. Am J Med Genet (1985) 1.08
Pyle's disease (familial metaphyseal dysplasia). A presentation of two cases and argument for its separation from craniometaphyseal dysplasia. J Bone Joint Surg Am (1970) 1.08
Recessive multiple epiphyseal dysplasia (rMED): phenotype delineation in eighteen homozygotes for DTDST mutation R279W. J Med Genet (2003) 1.07
The effect of moderate alcohol consumption on adiponectin oligomers and muscle oxidative capacity: a human intervention study. Diabetologia (2007) 1.07
Environmental aspects in pediatrics. New item in the European Journal of Pediatrics. Eur J Pediatr (1995) 1.06
Growing tumors induce hypersensitivity to endotoxin and tumor necrosis factor. Infect Immun (1987) 1.06
Heterozygous glycine substitution in the COL11A2 gene in the original patient with the Weissenbacher-Zweymüller syndrome demonstrates its identity with heterozygous OSMED (nonocular Stickler syndrome). Am J Med Genet (1998) 1.06
Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie (2010) 1.06
Isoflavonoid compounds extracted from Pueraria lobata suppress alcohol preference in a pharmacogenetic rat model of alcoholism. Alcohol Clin Exp Res (1996) 1.06
Insulin decreases human adiponectin plasma levels. Horm Metab Res (2003) 1.05
Duplicate publication and related problems. Arch Dis Child (1990) 1.05
Clinical and ultrastructural findings in three patients with geleophysic dysplasia. Am J Med Genet (1996) 1.05
Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet (1989) 1.05
Heterogeneity of Morquio disease. Clin Genet (1986) 1.05
Atelosteogenesis. Am J Med Genet (1982) 1.04
Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance. Eur J Clin Nutr (2006) 1.03
Heterogeneity in Schwartz-Jampel chondrodystrophic myotonia. Eur J Pediatr (1997) 1.03
New isoforms of multifunctional calcium/calmodulin-dependent protein kinase II. FEBS Lett (1993) 1.03
The systemic mucopolysaccharidoses. Ergeb Inn Med Kinderheilkd (1972) 1.03